2003
Cooperated with the University of Hong Kong to successfully detect SARS virus specimens in 15 minutes, reported by major media
2006
Chaozhou reagent production workshop obtained the national GMP certification
2007
Honorary Certificate of Credit Enterprise
Obtained ISO9001, ISO13485 certification
2008
Won the "Model Award in Support of Women's Charity" jointly issued by the National Women's Federation and the China Women's Development Foundation
2008 "Key Enterprise for Tax Creation"
Guangdong Hybribio Biotech Co., Ltd. and Chaozhou Hybribio Biochemistry Ltd. identified as high-tech enterprises
2009
Received the "Social Responsibility Award" from the Chinese Physician Association
2009 " Key Enterprise for Tax Creation"
2010
Won the "China Women's Charity Award" from the National Women's Federation and the China Women's Development Foundation
2010 “ Key Enterprise for Tax Creation” (chemical company)
Advanced Company of Production Safety in Chaozhou in 2010
2011
2011 "Key Enterprise for Tax Creation"
Chaozhou Advanced Collective
Major taxpayers of the year
Hybribio series products (21 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, etc.) participated in the WHO "HPV" laboratory network test, and the identification results met the clinical requirements of experimental testing.
2012
Awarded Top 10 Enterprises with Most Investment Value in China's Healthcare Industry in the 6th China Healthcare Industry Investment and Financing Summit
Became a supplier for mobilizing military supplies
Biochip R & D and industrialization projects are listed as key projects in the “Twelfth Five-Year Plan” for the development of Guangdong's biomedical industry
Established Guangdong HPV-Related Diseases Molecular Diagnostic Engineering Technology R & D Center
Guangdong Innovative enterprises
2013
Became the key enterprise of Guangdong's strategic emerging industries
The Guangdong Provincial Economic and Information Commission and the Guangdong Provincial Department of Science and Technology announced “the 15th Guangdong Clean Production Enterprises List”
Approved by the Ministry of Human Resources and Social Security and the National Postdoctoral Management Committee to establish a postdoctoral research station
Hybribio serial products (21 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, etc.) participated in the WHO "HPV" laboratory network test, and the identification results met the clinical requirements of experimental testing.
2014
Guangdong Provincial Enterprise Technology Center
"Biochip R & D and Industrialization" became a pilot project for the regional development of strategic emerging industries by the National Development and Reform Commission and won central and local financial support
Hybribio serial products (21 HPV GenoArray Diagnostic Kit, 13 High-risk HPV Real-time PCR Kit, 14 High-risk HPV with 16/18 Genotyping Real-time PCR Kit, etc.) participated in the WHO "HPV" laboratory network test, and the identification results met the clinical requirements of experimental testing.
Hybribio's Chief Scientist Dr. Xie Longxu was selected in o the "Sailing Plan" to be trained as high-level talents
2015
Selected as an Enterprise with Intellectual Property Advantages in Chaozhou
CT/NG/UU Real-time PCR Kit won the Third Prize of Chaozhou Science and Technology Progress Award
Hearing Loss Susceptibility GenoArray Diagnostic Kit won the second prize of Chaozhou Science and Technology Progress Award
Class A Medical Device Manufacturer for Quality Credit in Guangdong in 2015
2016
HPV Genotyping Diagnostic Kits and Gene Chip Preparation (ZL200710030723.6) method won the Gold Award of 2016 Chinese Invention Patent Award
Thalassemia GenoArray Diagnostic Kit won the First Prize of Chaozhou Science and Technology Progress Award
Class A Medical Device Manufacturer for Quality Credit in Guangdong in 2016
2017
Thalassemia GenoArray Diagnostic Kit won the First Prize of Chaozhou Science and Technology Progress Award
2017 National Enterprise with Intellectual Property Advantages
National Application and Demonstration Center for Genetic Diagnostic Technology
2018
The China Cancer Foundation awarded the "Social Welfare Award"
Won the Technology Achievement Award of 2018 Hong Kong Awards for Industry and Commerce
Top 50 Biotechnological Innovative Enterprises in Guangdong, Hong Kong and Macau Greater Bay Area in 2018
Approved by Guangdong Provincial Department of Human Resources and Social Security to establish a doctoral workstation in Guangdong Province
2019
China Cancer Foundation awarded the Social Welfare Award
Top 50 Leading Biotechnological Innovative Enterprises in Guangdong, Hong Kong and Macau Greater Bay Area in 2018
Top 100 Enterprises with Most Investment Value - Golden Bull Award for Listed Companies
Honor Award for the Cooperation and Development of Maternal and Child Health Industry
Annual Rising Award for Listed Companies in Guangdong, Hong Kong, Macao Greater Bay Area in 2019